Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Protagonist Therapeutics reports initial phase II data on PTG-300 in polycythemia vera

May 8, 2020

Positive topline results from global phase III INNO2VATE program of vadadustat

May 6, 2020

Regenacy Pharmaceuticals discloses HDAC1 and/or HDAC2 inhibitors

April 21, 2020

Chinese regulatory approval granted to initiate phase II/III study of HBM-9161 in ITP

April 16, 2020

SP-8008 prevents thrombus formation without inducing bleeding by blocking vWF-GP Ib interaction

April 15, 2020

New t-PA, u-PA and plasmin inhibitors presented by Alxerion Biotech

April 9, 2020

Catalyst announces pivotal phase III design for MarzAA

April 8, 2020

FDA approves Reblozyl to treat anemia in MDS

April 6, 2020

FDA approves Sevenfact for hemophilia A and B

April 2, 2020

FORMA Therapeutics identifies new pyruvate kinase PKLR activators

April 2, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...